Companies / Impel Neuropharma Inc
Impel Neuropharma Inc
IMPLIMPLQCIK 1445499
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 27, 2021 | KKR Iris Investors LLC 10% owner | Buy Open-market buy | Common Stock | $16.50M | +1.1M +40.70% | 3,802,638 | high |
| Apr 27, 2021 | Norwest Venture Partners XIV, LP 10% owner | Buy Open-market buy | Common Stock | $12.38M | +825K +36.63% | 3,077,198 | high |
| Apr 27, 2021 | 5AM Ventures V, L.P. 10% owner | Buy Open-market buy | Common Stock | $8.63M | +575K | 575,000 | high |
| Apr 27, 2021 | Vivo Capital IX, LLC 10% owner | Buy Open-market buy | Common Stock | $7.58M | +506K +24.91% | 2,535,115 | high |
| Apr 27, 2021 | venBio Global Strategic Fund II L.P. 10% owner | Buy Open-market buy | Common Stock | $6.75M | +450K +19.48% | 2,759,791 | high |
| Apr 27, 2021 | KKR Iris Investors LLC 10% owner | Other Other (per filing) | Common Stock | $1.60M | +119K +4.59% | 2,702,638 | low |
| Apr 27, 2021 | 5AM Ventures V, L.P. 10% owner | Other Derivative conversion | Common Stock | $1.37M | +101K +4.59% | 2,309,791 | low |
| Apr 27, 2021 | Norwest Venture Partners XIV, LP 10% owner | Other Derivative conversion | Common Stock | $1.34M | +99K | 98,927 | low |